Analysis of three human interleukin 5 structures suggests a possible receptor binding mechanism (Q41737199)

8 October 2017

1 reference

title

Analysis of three human interleukin 5 structures suggests a possible receptor binding mechanism (English)

1 reference

8 October 2017

Verschelde JL

1

1 reference

8 October 2017

Ampe C

2

1 reference

8 October 2017

Guisez Y

3

1 reference

8 October 2017

Oefner C

4

1 reference

8 October 2017

Vandekerckhove J

5

1 reference

8 October 2017

Tavernier J

6

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

8 October 2017

1 reference

8 October 2017

424

1 reference

8 October 2017

3

1 reference

8 October 2017

121-126

1 reference

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Haemopoietic receptors and helical cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Refined crystal structure and mutagenesis of human granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Purification, characterisation and crystallisation of selenomethionyl recombinant human interleukin-5 from Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Expression, purification and crystallization of fully active, glycosylated human interleukin-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Expression of human and murine interleukin-5 in eukaryotic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

High-level production of murine interleukin-5 (IL-5) utilizing recombinant baculovirus expression. Purification of the rIL-5 and its use in assessing the biologic role of IL-5 glycosylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Structural mechanisms for domain movements in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Specific human granulocyte-macrophage colony-stimulating factor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Mutants of single chain interleukin 5 show asymmetric recruitment of receptor alpha and betac subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Creation of a biologically active interleukin-5 monomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Interleukin-6: structure-function relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Crystallization and Preliminary X-ray Diffraction Studies of Recombinant Human Interleukin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Low-resolution structure of recombinant human granulocyte-macrophage colony stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Role of sugar chains in the in-vitro activity of recombinant human interleukin 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900146-X

10.1016/S0014-5793(98)00146-X

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference